Skip to main content
NIH funding notice RFA-AI-19-072

Novel Therapeutics Directed to Intracellular HIV Targets (R21 Clinical Trial Not Allowed)

Closed on July 1, 2020.

Posted
December 19, 2019
Close date
July 1, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,508,627 in first-year total cost, median $242,250.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 RB-A (S5)]7

Most frequent institutions

  1. ALBERT EINSTEIN COLLEGE OF MEDICINE1
  2. CASE WESTERN RESERVE UNIVERSITY1
  3. HARVARD MEDICAL SCHOOL1
  4. J. DAVID GLADSTONE INSTITUTES1
  5. RESEARCH INST OF FOX CHASE CAN CTR1
Competing awards under RFA-AI-19-072 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Targeting Tat/TAR interactions with the superelongation complex to develop novel treatments for HIV/AIDS1R21AI156915-01SCHULZE-GAHMEN, URSULAJ. DAVID GLADSTONE INSTITUTES, CA$283,500ZAI1
2021Characterization of New Allosteric Inhibitors that Disrupt HIV-1 Integrase Dimerization1R21AI157375-01ANDRAKE, MARK DAVIDRESEARCH INST OF FOX CHASE CAN CTR, PA$280,500ZAI1
2021Structure-based design of stapled peptides to target Gag-Pol and INI1 interaction to block assembly1R21AI156932-01KALPANA, GANJAM VALBERT EINSTEIN COLLEGE OF MEDICINE, NY$271,500ZAI1
2021Single-chain antibodies to block HIV transcription and prevent reactivation from latently infected resting CD4+ T cells1R21AI156897-01STODDART, CHERYLUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$242,250ZAI1
2021A New Paradigm for HIV Treatment: Targeted Degradation of HIV Reverse Transcriptase via the Ubiquitin-Proteasome Pathway1R21AI157362-01REYNOLDS, ROBERT CUNIVERSITY OF ALABAMA AT BIRMINGHAM, AL$205,425ZAI1
2021Multiplex discovery of synthetic host-protein combinations that inhibit HIV1R21AI156907-01MATREYEK, KENNETH ACASE WESTERN RESERVE UNIVERSITY, OH$201,250ZAI1
2021Small molecule degraders of HIV-1 Nef1R21AI156928-01YANG, PRISCILLA LI-NINGHARVARD MEDICAL SCHOOL, MA$24,202ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.